ResMed Stock (NYSE: RMD) stock price, news, charts, stock research, profile.
|Vol / Avg.763.229K / 1.514M||Mkt Cap23.957B|
|Day Range162.475 - 163.925||52 Wk Range132.240 - 243.520|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-10-27||Morgan Stanley||Sean Laaman||Upgrades||Equal-WeightOverweight||Announces||-||169.00|
|2023-10-12||RBC Capital||Craig Wong-Pan||Downgrades||OutperformSector Perform||Lowers||273.00||202.00|
|Ticker||Company||Chg %||Mkt Cap|
You can purchase shares of ResMed (NYSE: RMD) through any online brokerage.
The latest price target for ResMed (NYSE: RMD) was reported by Mizuho on Tuesday, October 31, 2023. The analyst firm set a price target for 160.00 expecting RMD to fall to within 12 months (a possible -1.76% downside). 19 analyst firms have reported ratings in the last year.
The stock price for ResMed (NYSE: RMD) is $162.87 last updated December 8, 2023 at 9:00 PM UTC.
A quarterly cash dividend of $0.48 per share of Class A Common Stock. The quarterly cash dividend was payable on December 14, 2023 to stockholders of record on November 8, 2023.
ResMed’s Q2 earnings are confirmed for Thursday, January 25, 2024.
There is no upcoming split for ResMed.
ResMed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.